Acasti Pharma Inc (APO):企業の財務・戦略的SWOT分析

◆英語タイトル:Acasti Pharma Inc (APO) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15113
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥39,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥79,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥119,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Acasti Pharma Inc (Acasti), a subsidiary of Neptune Technologies & Bioressources Inc, is a biopharmaceutical company that conducts research, development, and commercialization of krill oil-based forms of omega-3 fatty acids. The company develops phospholipid therapies for abnormalities in blood lipids, and treatment and prevention of various cardiometabolic disorders. Its product include CaPre, a drug product candidate, used for the treatment of hypertriglyceridemia, which is a condition characterized by abnormally high levels of triglycerides in the bloodstream; and Onemia, a medical food that is used in the dietary management of diseases associated with omega-3 phospholipids deficiency related to cardiometabolic disorders. The company has operations in Canada. Acasti is headquartered in Laval, Quebec, Canada.

Acasti Pharma Inc Key Recent Developments

Feb 14,2019: Acasti Pharma provides business update for the third quarter of fiscal 2019
Nov 14,2018: Acasti Pharma provides business update for second quarter of fiscal 2019
Sep 24,2018: Acasti Pharma names Jean-François Boily as Vice President of Finance
Aug 29,2018: Acasti Pharma announces the election of its directors, changes to its stock option plan and other related matters approved at its AGM
Aug 14,2018: Acasti Pharma provides business update for the first quarter of fiscal 2019

This comprehensive SWOT profile of Acasti Pharma Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Acasti Pharma Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Acasti Pharma Inc – Key Information
Acasti Pharma Inc – Overview
Acasti Pharma Inc – Key Employees
Acasti Pharma Inc – Key Employee Biographies
Acasti Pharma Inc – Key Operational Heads
Acasti Pharma Inc – Major Products and Services
Acasti Pharma Inc – History
Acasti Pharma Inc – Company Statement
Acasti Pharma Inc – Locations And Subsidiaries
Acasti Pharma Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Acasti Pharma Inc – Business Description
Acasti Pharma Inc – Corporate Strategy
Acasti Pharma Inc – SWOT Analysis
SWOT Analysis – Overview
Acasti Pharma Inc – Strengths
Acasti Pharma Inc – Weaknesses
Acasti Pharma Inc – Opportunities
Acasti Pharma Inc – Threats
Acasti Pharma Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Acasti Pharma Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Acasti Pharma Inc, Key Information
Acasti Pharma Inc, Key Ratios
Acasti Pharma Inc, Share Data
Acasti Pharma Inc, Major Products and Services
Acasti Pharma Inc, History
Acasti Pharma Inc, Key Employees
Acasti Pharma Inc, Key Employee Biographies
Acasti Pharma Inc, Key Operational Heads
Acasti Pharma Inc, Other Locations
Acasti Pharma Inc, Subsidiaries
Acasti Pharma Inc, Key Manufacturing facilities
Acasti Pharma Inc, Key Competitors
Acasti Pharma Inc, SWOT Analysis
Acasti Pharma Inc, Ratios based on current share price
Acasti Pharma Inc, Annual Ratios
Acasti Pharma Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Acasti Pharma Inc, Performance Chart
Acasti Pharma Inc, Ratio Charts

★海外企業調査レポート[Acasti Pharma Inc (APO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Prothena Corp Plc (PRTA):企業の財務・戦略的SWOT分析
    Summary Prothena Corp Plc (Prothena) discovers and develops therapies for the treatment of neurological disorders. It is evaluating Prasinezumab (PRX002/RG7935), a monoclonal antibody targeting alpha-synuclein protein, against Parkinson’s disease and other related synucleinopathies; and PRX004, an i …
  • Securitas AB (SECU B):企業の財務・戦略的SWOT分析
    Securitas AB (SECU B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • CaroGen Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary CaroGen Corp (CaroGen) is an immunotherapy company that offers platform technology development services. The company develops and commercializes virus-like vesicle based therapeutic vaccines. It utilizes its virus-like vesicle platform technology for the development of vaccines for infectiou …
  • Putnam Investments LLC:企業の戦略的SWOT分析
    Putnam Investments LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Glanbia plc:企業のM&A・事業提携・投資動向
    Glanbia plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Glanbia plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • IFFCO-Tokio General Insurance Co Ltd:企業の戦略・SWOT・財務分析
    IFFCO-Tokio General Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary IFFCO-Tokio General Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • The Brookwood Partnership Ltd:企業の戦略・SWOT・財務情報
    The Brookwood Partnership Ltd - Strategy, SWOT and Corporate Finance Report Summary The Brookwood Partnership Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Woodside Petroleum Limited:企業の戦略・SWOT・財務分析
    Woodside Petroleum Limited - Strategy, SWOT and Corporate Finance Report Summary Woodside Petroleum Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Akzo Nobel NV (AKZA):企業の財務・戦略的SWOT分析
    Akzo Nobel NV (AKZA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Chemring Ordnance, Inc.:企業の戦略・SWOT・財務情報
    Chemring Ordnance, Inc. - Strategy, SWOT and Corporate Finance Report Summary Chemring Ordnance, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • JenaValve Technology Inc:医療機器:M&Aディール及び事業提携情報
    Summary JenaValve Technology Inc (JenaValve Technology), a subsidiary of JenaValve Technology GmbH, is a medical device company that develops and manufactures transcatheter aortic valve replacement (TAVR) systems for transapical and transfemoral implantation. The company’s TAVR system is an investig …
  • Calfrac Well Services Ltd (CFW):企業の財務・戦略的SWOT分析
    Calfrac Well Services Ltd (CFW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Shermco Industries Inc:企業の戦略的SWOT分析
    Shermco Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Evgen Pharma Plc (EVG):企業の財務・戦略的SWOT分析
    Summary Evgen Pharma Plc (Evgen Pharma), formerly Evgen Pharma Ltd is a clinical-stage drug development company. It is focused on the development of sulforaphane-based compounds for the treatment of cancer and neurological disease. Its pipeline product SFX-01 targets STAT3 signalling to inhibit stem …
  • Proteus Digital Health Inc:医療機器:M&Aディール及び事業提携情報
    Summary Proteus Digital Health Inc (Proteus) is a digital medicine company that develops and sells medicines for chronic diseases through in-house research and through partnership with the pharmaceutical, medical device and biotechnology companies. Its flagship product, Proteus Discover digital medi …
  • XPO Logistics, Inc.:企業のM&A・事業提携・投資動向
    XPO Logistics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's XPO Logistics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Vietnam Dairy Products Joint Stock Co:戦略・SWOT・企業財務分析
    Vietnam Dairy Products Joint Stock Co - Strategy, SWOT and Corporate Finance Report Summary Vietnam Dairy Products Joint Stock Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Tactical Missiles Corporation:企業の戦略・SWOT・財務情報
    Tactical Missiles Corporation - Strategy, SWOT and Corporate Finance Report Summary Tactical Missiles Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Korea Aerospace Industries Ltd:企業の戦略・SWOT・財務分析
    Korea Aerospace Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Korea Aerospace Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Catholic Health Initiatives:企業の戦略・SWOT・財務情報
    Catholic Health Initiatives - Strategy, SWOT and Corporate Finance Report Summary Catholic Health Initiatives - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆